Topic-Based
Resource Centers

New Oral Anti-Coagulants

TAGS   AnticoagulationMedication safetyWarfarin

VIDEO

RELATED ARTICLES

 
Can dabigatran be used in pregnant women?

 Can dabigatran be used in pregnant women?

 

Using dabigatran anticoagulation treatment for pregnant women could potentially affect fetal blood coagulation, according to a study published in Obstetrics & Gynecology. Dabigatran may cross the placenta to the fetus.

More...

 
 
Apixaban cuts stroke risk regardless of BP control

 Apixaban cuts stroke risk regardless of BP control

 

A subanalysis of the Phase 3 ARISTOTLE trial indicates that apixaban reduces the risk of stroke regardless of whether a patient’s blood pressure is controlled.

More...

 
 
Anticoagulant dosing in obesity should be individualized and drug-specific

Anticoagulant dosing in obesity should be individualized and drug-specific

 

Obesity is a growing problem in the United States. We are often confronted with dosing drugs in an obese patient. Unfortunately, many clinical trials exclude or have limited overweight patients enrolled; thus, optimal dosing for both safety and efficacy in this population is lacking.

More...

 
 
Rivaroxaban has more indications

Rivaroxaban has more indications

 

The FDA has increased the indications for rivaroxaban. Patients with stents who receive oral anticoagulants do not need aspirin. Low-dose aspirin has shown some ability to reduce venous thromboembolism.

More...

 
 
New oral anticoagulants increase risk for GI bleeding

New oral anticoagulants increase risk for GI bleeding

 

Patients taking the new generation of oral anticoagulants are associated with a significantly higher risk of gastrointestinal bleeding, according to a study published in the July 2013 issue of Gastroenterology.

More...

 
 
Cardiologists prescribing rivaroxaban more than warfarin

Cardiologists prescribing rivaroxaban more than warfarin

 

Cardiologists are increasingly bypassing the anticoagulant warfarin in favor of rivaroxaban, a more-expensive alternative with fewer side effects, according to the IMS NPA Weekly.

More...

 
 
Anticoagulant use predicts survival in metastatic prostate cancer

Anticoagulant use predicts survival in metastatic prostate cancer

 

Anticoagulation while on docetaxel (Taxotere) chemotherapy is an independent predictor of survival in men with metastatic castration-resistant prostate cancer (mCRPC).

More...

 
 
Web-based program aids clinicians in anticoagulation treatment

Web-based program aids clinicians in anticoagulation treatment

 

A new web-based program aims to help clinical pharmacists and other healthcare professionals achieve the best possible outcomes for their patients on antithrombotic medications.

More...

 
 
First study of patient satisfaction with a pharmacy program released by Henry Ford Hospital

First study of patient satisfaction with a pharmacy program released by Henry Ford Hospital

 

Implementation of a pharmacy service that provides dosing, monitoring, education, and ensured safe transition from the inpatient to the outpatient setting is associated with improved patient satisfaction with overall care and with care related to anticoagulation management, according to a study published in the Annals of Pharmacotherapy.

More...

 
 

CME

 

New Anticoagulants for Stroke Prophylaxis in Patients with Nonvalvular Atrial Fibrillation

 

Release Date: May 31, 2013
Expiration Date: May 31, 2015
Estimated time to complete activity: 2 hours

 

Atrial fibrillation (AF) is a major and growing health issue in the United States. Stroke prophylaxis is an important part of the management of AF. Anticoagulation for stroke prophylaxis is appropriate for most patients with AF. Warfarin has been the mainstay treatment for decades. Over the last few years, an oral direct thrombin inhibitor (DTI) and 2 direct Factor Xa inhibitors (DFXaIs) have been approved for use as stroke prophylaxis in patients with nonvalvular AF. Warfarin remains the anticoagulant of choice for patients with valvular AF. It is important for hospitalists to have a working knowledge of the different anticoagulants available for stroke prophylaxis in AF as well as current stroke risk-stratification recommendations.

 

View Activity